Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS??? DEFICIT

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
AOCI Attributable to Parent
Beginning balance (in shares) at Dec. 31, 2020 43,836,109          
Beginning balance at Dec. 31, 2020 $ 151,938          
Ending Balance (in shares) at Mar. 31, 2021 43,836,109          
Ending balance at Mar. 31, 2021 $ 151,938          
Beginning balance at Dec. 31, 2020 (113,945)   $ 0 $ 16,261 $ (130,208) $ 2
Common stock, beginning balance (in shares) at Dec. 31, 2020     11,882,286      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares from stock option exercises (in shares)     947,305      
Issuance of common shares from stock option exercises 248     248    
Stock-based compensation 1,824     1,824    
Foreign currency translation adjustments, net of tax (1)         (1)
Net loss (8,983)       (8,983)  
Ending balance at Mar. 31, 2021 $ (120,857)   $ 0 18,333 (139,191) 1
Common stock, ending balance (in shares) at Mar. 31, 2021     12,829,591      
Preferred stock, beginning balance (in shares) at Dec. 31, 2021 0 0        
Beginning balance at Dec. 31, 2021 $ 112,301 $ 0 $ 0 294,230 (181,898) (31)
Common stock, beginning balance (in shares) at Dec. 31, 2021 64,324,628   64,324,628      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares from stock option exercises (in shares) 564,083   564,083      
Issuance of common shares from stock option exercises $ 559     559    
Vesting of restricted stock units (in shares)     593      
Stock-based compensation 3,425     3,425    
Foreign currency translation adjustments, net of tax 54         54
Net loss $ (13,838)       (13,838)  
Preferred stock, ending balance (in shares) at Mar. 31, 2022 0 0        
Ending balance at Mar. 31, 2022 $ 102,501 $ 0 $ 0 $ 298,214 $ (195,736) $ 23
Common stock, ending balance (in shares) at Mar. 31, 2022 64,889,304   64,889,304